Retention, Urinary

0
Pipeline Programs
1
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

C
ColoplastAustralia - Mulgrave
4 programs
SpeediCath® Standard femaleN/A1 trial
SpeediCath® Standard maleN/A1 trial
SpeediCath® Standard male new coatingN/A1 trial
SpeediCath® Standard male or femaleN/A1 trial
Active Trials
NCT04557787CompletedEst. May 2021
NCT04543136CompletedEst. Jan 2021
NCT06985888CompletedEst. Jun 2025
+1 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ColoplastSpeediCath® Standard male new coating
ColoplastSpeediCath® Standard female
ColoplastSpeediCath® Standard male
ColoplastSpeediCath® Standard male or female

Clinical Trials (4)

NCT06985888ColoplastSpeediCath® Standard male new coating

New Coating for Urinary Intermittent Catheters

Start: May 2025Est. completion: Jun 2025
N/ACompleted
NCT04557787ColoplastSpeediCath® Standard female

Investigation of Non-CE Marked Intermittent Catheters for Females

Start: Dec 2020Est. completion: May 2021
N/ACompleted
NCT04543136ColoplastSpeediCath® Standard male

Investigation of Non-CE Marked Intermittent Catheters.

Start: Oct 2020Est. completion: Jan 2021
N/ACompleted
NCT04445051ColoplastSpeediCath® Standard male or female

Investigation of New Intermittent Catheters in Healthy Volunteers

Start: Mar 2020Est. completion: Sep 2020
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space